phenyl acetate has been researched along with Diabetic Neuropathies in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.56) | 18.7374 |
1990's | 9 (25.00) | 18.2507 |
2000's | 22 (61.11) | 29.6817 |
2010's | 3 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Mello, JCP; de Miranda Neto, MH; do Nascimento Bonato Panizzon, CP; Longhini, R; Ramalho, FV; Zanoni, JN | 1 |
Almeida, BC; Almeida, FR; Brito, SM; Carvalho, FC; Chaves, MH; Piaulino, CA | 1 |
Choi, SZ; Kim, JK; Kim, N; Kim, SH; Kim, SY; Kim, YJ; Kuh, HJ; Nam, MK; Rhim, H; Son, M; Yoon, SK | 1 |
Kingham, JG; Richardson, CE; Williams, DW | 1 |
Calcutt, NA; Higuera, ES; Luo, ZD; Myers, RR; Song, YH; Svensson, CI; Valder, CR | 1 |
Backonja, M; Glanzman, RL | 1 |
Bilinska, M; Paradowski, B | 1 |
Brunnmüller, U; Junker, U | 1 |
Cook, JA; Ewy, WE; Lockwood, PA; Mandema, JW | 1 |
Andrews, NA; Blake, R; Maneuf, YP; McKnight, AT | 1 |
Drass, M; Nalamachu, S; Patel, N; White, WT | 1 |
Hevia, A; Hinchey, P; Hobgood, C | 1 |
Fox, SD; Henderson, LW | 1 |
Backonja, M; Beydoun, A; Edwards, KR; Fonseca, V; Garofalo, E; Hes, M; LaMoreaux, L; Schwartz, SL | 1 |
Dotson, RM; Low, PA | 1 |
Gorson, KC; Herman, R; Rand, WM; Ropper, AH; Schott, C | 1 |
Seidl, JJ; Slawson, JG | 1 |
Ebbert, J; Schiebel, NE | 1 |
Margolis, K | 1 |
Leckband, SG; Moorhouse, DF; Morello, CM; Sahagian, GA; Stoner, CP | 1 |
Backonja, MM | 1 |
Simon, HB | 1 |
Benito-León, J; Berbel, A; García-Morales, I; Martínez-Salio, A; Porta-Etessam, J | 1 |
Pérez, HE; Sánchez, GF | 1 |
Bramwell, S; Gonzalez, MI; Lee, K; Patel, MK; Pinnock, RD | 1 |
Buffa, C; Chiroli, S; Dallocchio, C; Mazzarello, P | 1 |
Cynwyd, B; Derk, CT | 1 |
Evans, MF; Papoushek, C; Rawn, T | 1 |
Kamp-Jensen, M; Werner, MU | 1 |
Block, F | 1 |
Hemstreet, B; Lapointe, M | 1 |
Brooks-Rock, K | 1 |
Iwamoto, T; Miki, S; Sato, S; Yasuda, T; Yoshinaga, N | 1 |
Azulay, JP; Pouget, J | 1 |
Dvornik, E; Gabbay, KH; Kinoshita, JH; Krami, M; Merola, LO; Sestanj, K; Simard-Duquesne, N; Varma, SD | 1 |
Peyer, C; Rieder, HP | 1 |
4 review(s) available for phenyl acetate and Diabetic Neuropathies
Article | Year |
---|---|
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
Topics: Acetates; Amines; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Herpesviridae Infections; Humans; Neuralgia; Pain; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Syndrome | 2003 |
[Gabapentin--yet another antiepileptic agent for the treatment of neuropathic pain?].
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Herpesviridae Infections; Humans; Multicenter Studies as Topic; Neuralgia | 2001 |
[Gabapentin therapy for pain].
Topics: Acetates; Amines; Analgesics; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Migraine Disorders; Pain; Reflex Sympathetic Dystrophy; Trigeminal Neuralgia | 2001 |
Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy.
Topics: Acetates; Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Humans | 2001 |
8 trial(s) available for phenyl acetate and Diabetic Neuropathies
Article | Year |
---|---|
Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.
Topics: Acetates; Activities of Daily Living; Aged; Aged, 80 and over; Amines; Analgesics; Anesthetics, Local; Chronic Disease; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Low Back Pain; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Pilot Projects; Quality of Life; Treatment Outcome | 2003 |
Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Topics: Acetates; Acrylic Resins; Acrylonitrile; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Urea Nitrogen; Body Fluids; Body Temperature; Cations; Diabetic Nephropathies; Diabetic Neuropathies; Hemodialysis Solutions; Hemodynamics; Hemofiltration; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis; Weight Loss | 1993 |
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement; Quality of Life | 1998 |
Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement | 1999 |
Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.
Topics: Acetates; Adrenergic Uptake Inhibitors; Aged; Amines; Amitriptyline; Analgesics; Cross-Over Studies; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1999 |
Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus.
Topics: Acetates; Affect; Ambulatory Care; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Drug Administration Schedule; Gabapentin; gamma-Aminobutyric Acid; Humans; Placebos; Quality of Life; Treatment Outcome | 1999 |
Gabapentin therapy for diabetic neuropathic pain.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Treatment Outcome | 2000 |
Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Amitriptyline; Analgesics; Ataxia; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dizziness; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement; Paresthesia; Pilot Projects; Salivary Glands; Sleep Stages; Treatment Outcome | 2000 |
24 other study(ies) available for phenyl acetate and Diabetic Neuropathies
Article | Year |
---|---|
Ethyl Acetate Fraction from Trichilia catigua Confers Partial Neuroprotection in Components of the Enteric Innervation of the Jejunum in Diabetic Rats.
Topics: Acetates; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enteric Nervous System; Glial Fibrillary Acidic Protein; Jejunum; Male; Meliaceae; Neuroglia; Neurons; Neuroprotection; Neuroprotective Agents; Plant Extracts; Rats; Rats, Wistar; S100 Proteins | 2019 |
The stem bark extracts of Cenostigma macrophyllum attenuates tactile allodynia in streptozotocin-induced diabetic rats.
Topics: Acetates; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ethanol; Fabaceae; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Nitrergic Neurons; Opioid Peptides; Pain Threshold; Phytotherapy; Plant Bark; Plant Extracts; Plant Stems; Plants, Medicinal; Rats; Rats, Wistar; Receptors, Opioid; Solvents; Time Factors | 2013 |
Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro.
Topics: Acetates; Animals; Animals, Newborn; Cell Survival; Chemical Fractionation; Diabetic Neuropathies; Dioscorea; Dose-Response Relationship, Drug; Ethanol; Ganglia, Spinal; Nerve Growth Factors; Neurites; Neurons; PC12 Cells; Phosphorylation; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, trkA; Schwann Cells; Sciatic Nerve; Solvents; Up-Regulation | 2011 |
Gabapentin induced cholestasis.
Topics: Acetates; Amines; Anticonvulsants; Cholestasis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Humans; Liver Function Tests; Male; Middle Aged | 2002 |
Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.
Topics: Acetates; Amines; Animals; Calcium Channels; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Humans; Ligation; Male; Pain; Pain Measurement; Protein Subunits; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Spinal Cord; Up-Regulation | 2002 |
[Gabapentin in the treatment of neuropathic pain in patients with type 2 diabetes mellitus].
Topics: Acetates; Aged; Amines; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Surveys and Questionnaires | 2003 |
[Efficacy and tolerability of gabapentin in the treatment of patients with neuropathic pain. Results of an observational study involving 5620 patients].
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Neuralgia; Pain Measurement; Patient Satisfaction; Time Factors | 2003 |
The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic pain.
Topics: Acetates; Amines; Analgesics; Chronic Disease; Clinical Trials, Phase II as Topic; Computer Simulation; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Models, Chemical; Models, Statistical; Pain; Pain Measurement | 2003 |
Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat.
Topics: Acetates; Amines; Animals; Blood Glucose; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Pain; Pain Measurement; Physical Stimulation; Potassium; Rats; Trigeminal Nuclei | 2004 |
Profiles in patient safety: when an error occurs.
Topics: Acetates; Aged; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Administration Schedule; Emergency Medicine; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypotension; Hypoxia; Medication Errors; Pain; Phenytoin; Treatment Outcome | 2004 |
Symptomatic treatment of painful neuropathy.
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Neuralgia; Pain | 1998 |
Gabapentin for painful diabetic neuropathy.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Method; Gabapentin; gamma-Aminobutyric Acid; Humans; Pain; Randomized Controlled Trials as Topic; Reproducibility of Results | 1999 |
Gabapentin for painful diabetic neuropathy.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Humans; Pain | 1999 |
Gabapentin for painful diabetic neuropathy.
Topics: Acetates; Amines; Analgesics; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Humans; Pain | 1999 |
On call. I am a 49-year-old man with diabetes. I take Glucophage and I'm careful with my diet. I also walk three miles almost every day. My blood sugar is always below 150, usually in the 130s. My problem is tingling in my fingers and pain in my feet, whi
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged | 2000 |
Gabapentin in acute painful diabetic neuropathy.
Topics: Acetates; Acute Disease; Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Pain; Palliative Care | 2000 |
Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord.
Topics: Acetates; Amines; Animals; Antimanic Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Excitatory Postsynaptic Potentials; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Membrane Potentials; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Spinal Cord; Streptozocin; Synaptic Transmission; Tetrodotoxin | 2000 |
Malignant appearing cachexia in an older patient with Bruns-Garland syndrome.
Topics: Acetates; Aged; Amines; Analgesics; Cachexia; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Muscular Atrophy; Pain; Syndrome | 2000 |
Gabapentin or amitriptyline for painful diabetic neuropathy?
Topics: Acetates; Amines; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Family Practice; Gabapentin; gamma-Aminobutyric Acid; Humans; Treatment Outcome | 2000 |
Treating painful diabetic neuropathy with gabapentin.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Costs; Gabapentin; gamma-Aminobutyric Acid; Humans; Pain; Pain Measurement; Patient Selection; Treatment Outcome | 2001 |
Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model.
Topics: Acetates; Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Glucose; Hyperalgesia; Insulin; Male; Motor Neurons; Neural Conduction; Pain Threshold; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors | 2001 |
[Diabetic neuropathies].
Topics: Acetates; Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Controlled Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electrophysiology; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperglycemia; Immunoglobulins, Intravenous; Linoleic Acid; Pain; Prognosis | 2001 |
Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor.
Topics: Acetates; Administration, Oral; Alcohol Oxidoreductases; Animals; Cataract; Culture Techniques; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Fructose; Galactose; Galactosemias; Glucose; Isoquinolines; Lens, Crystalline; Rats; Sciatic Nerve; Sorbitol; Streptozocin; Sugar Alcohols | 1973 |
Sex differences in the serum lipoprotein relations of normal persons and multiple sclerosis patients.
Topics: Acetates; Adult; Age Factors; Cellulose; Diabetic Neuropathies; Electrophoresis; Female; Hernia; Humans; Lipoproteins; Male; Middle Aged; Multiple Sclerosis; Sex Factors; Spinal Cord Injuries | 1970 |